All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100 ...
KXAN Austin
CARDIFF, UK / ACCESSWIRE / June 3, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) just announced promising phase 2 results for its newly...
14 hours ago
Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 78% Today?
InvestorPlace
Biodexa Pharmaceuticals (NASDAQ:BDRX) stock is rocketing higher on Tuesday alongside heavy pre-market trading of the clinical-stage...
2 weeks ago
Biodexa Pharmaceuticals Unveils Series G Warrant - TipRanks.com
Tipranks
Biodexa Pharmaceuticals (BDRX) has released an update. Biodexa Pharmaceuticals has announced a new Series G Warrant allowing holders to purchase ordinary...
6 days ago
Biotech Shares Bid Up Premarket Following 9.9% Institutional Stake Disclosure
The Globe and Mail
Updated Price for MSCI EMI Index (ICE/US: DEM22). Charting, Price Performance, News & Related Contracts.
1 day ago
Biodexa Pharmaceuticals (LON:MTPH) Stock Price Crosses Above 50-Day Moving Average of $18.00
Defense World
Read Biodexa Pharmaceuticals (LON:MTPH) Stock Price Crosses Above 50-Day Moving Average of $18.00 at Defense World.
4 days ago
What's Going On With Biodexa Pharmaceuticals Stock? - Biodexa Pharmaceuticals (NASDAQ:BDRX)
Benzinga
Biodexa Pharmaceuticals (NASDAQ:BDRX) stock is trading higher. The company on Tuesday announced progress towards the treatment of Familial...
2 weeks ago
Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents And Young Adults With Devastating ...
Yahoo Finance
Registrational phase 3 clinical trials of Biodexa's (NASDAQ:BDRX) candidate eRapa are expected to start first quarter next year.
3 weeks ago
Biotech Shares Bid Up Premarket Following 9.9% Institutional Stake Disclosure
The Globe and Mail
Updated Price for Nasdaq 100 E-Mini (CME: NQU21). Charting, Price Performance, News & Related Contracts.
1 day ago
Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today?
InvestorPlace
Biodexa Pharmaceuticals stock is up alongside heavy trading of BDRX after announcing positive news from a brain cancer treatment trial.
2 months ago
Biodexa Pharmaceuticals Launches Series G Warrants - TipRanks.com
Tipranks
Biodexa Pharmaceuticals (BDRX) has released an update. Biodexa Pharmaceuticals has issued Series G Warrants, allowing holders to purchase ordinary shares...
2 weeks ago